Conventional adult mice were pretreated with metronidazole to make their intestinal tracts receptive to colonization by Clostridium botulinum. These mice, in groups of 10, were fed 0 (controls), 102, 103, 104, or 
105 spores had similar toxin levels in their large intestines 48 h later. Morbidity rates correlated better with toxin levels in the small intestines.
Infant botulism is the toxic infection in which toxin
produced by Clostridium botulinum colonizing the intestinal tract passes into the bloodstream and is carried by it to distant cholinergic neuromuscular junctions (1) . The toxin poisons these junctions by preventing the release of normal amounts of acetylcholine by nerve stimuli and thereby causes a syndrome of flaccid paralysis (8) .
The intraintestinal colonization phase of infant botulism has been duplicated by administering C. botulinum spores in toxin-free suspensions into the stomachs of 8-to 10-day-old mice, when the age-related susceptibility of the host species is highest (9) . Additionally, normally resistant adult mice are colonized when challenged orogastrically with the spores at the time their gut microfloras are suppressed by feedings of a mixture of kanamycin and erythromycin (2)-both broadspectrum antibiotics-or metronidazole (3), whose antimicrobial activity is limited to obligate anaerobes.
Although a recent publication reports that infant mice of certain age range develop botulism when given high challenge inocula of 107 or more C. botulinum type E spores (6) ,
intraintestinal growth of C. botulinum type A in our animal models has been nonsymptomatic. Its occurrence is therefore monitored by testing for botulinum toxin production in the gut. When toxin in colonized guts is titrated by the intraperitoneal (i.p.) route in normal mice, some samples have -1,000 mean lethal doses (LD50s). Since the intraintestinally formed toxin must be absorbed into the bloodstream before it can cause systemic effects, the failure of these toxin levels to cause overt botulism is attributed to most of the toxin being in the cecum and colon, from where it is poorly absorbed.
Although the colonization of conventional infant and antimicrobially treated adult mice is nonsymptomatic, that * Corresponding author. (10) . These illnesses could be responses to toxin absorbed directly after production, but the possible involvement of coprophagically acquired toxin cannot be eliminated.
The present communication describes findings differing from those reported previously (3); botulism was elicited when C. botulinum type A or B spores were administered to conventional adult mice that had been pretreated with metronidazole to make their guts susceptible to colonization by the inoculum. Mice were housed in cages with screen floors to reduce the amount of feces accessible to the animals and were distributed in a manner that made it possible to evaluate how much coprophagy contributed to morbidity rates.
MATERIALS AND METHODS Spores. Spores of C. botulinum type A strain 62 and type B strain Okra were obtained by incubating the cultures in a freshly prepared medium of 2.5% Trypticase, 2.5% Thiotone, and 2.0% Phytone (all from BBL Microbiology Systems, Cockeysville, Md.) for 5 to 7 days at 37°C. Growth was harvested and washed 7 to 10 times with distilled water by centrifugation.
Viable spores were enumerated with the five-tube mostprobable-number method, using cooked meat medium (Difco Laboratories, Detroit, Mich.) made with 0.5% glucose-0.2% soluble starch. Inocula were dilutions of a stock suspension portion that was heated in an 80°C water bath for 15 min. Growth was recorded after incubations of at least 7 days at 37°C, and those in the endpoint tubes were tested for the presence of the appropriate type of toxin. Viable counts were confirmed periodically.
The stock spore suspension was diluted with physiological saline so that 0.5 ml contained the highest spore dose of the experiment. This dilution was heated in an 80°C water bath for 15 min before being diluted for the other challenge doses. The heating assured the absence of toxin in the inocula; 0. Numbers of sick mice and the cumulative dead were recorded at least once a day.
Toxin tests. Intraintestinal toxin production was used to determine whether mice were colonized by the intragastrically administered spores. At 48 h postchallenge, up to three freshly excreted fecal pellets were collected from each mouse, or the large intestine with its digesta was removed after the mouse was sacrificed. The pools of feces or the gut samples were homogenized with 0.4% phosphate-0.2% gelatin (pH 6.2). The homogenate was held overnight at 4°C, and 0.5 ml of the supernatant (extract), obtained by centrifugation, was injected i.p. into a normal mouse. The extracts killing the toxin test mice within 3 days were considered to contain botulinum toxin, since the appropriate type of botulinum antitoxin neutralized the toxicity of representative extracts. It was necessary to dilute some extracts to reduce a nonbotulinum lethal agent(s) to levels that did not interfere with the test (3).
Specimens to be titrated were weighed. Feces were extracted with 9 times their amount (wt/vol) of buffer-gelatin to yield a 1:10 dilution; intestinal segments were extracted to yield 1:4 or 1:5 dilutions. Serial twofold dilutions of the extracts were injected i.p. in 0.5-ml amounts into their own pair of mice. The LD5( dilution was the one killing one of the two mice within 3 days; when this effect was not obtained, the LD50 dilution was calculated as midway between the highest dilution lethal for both mice and the next dilution killing neither of the pair. Toxin titrated in feces was measured as LD50 per gram (wet weight); amounts in gut segments were totals in the samples.
Distribution of toxin. Metronidazole-treated mice were challenged with 102 or 105 C. botulinum spores and then distributed so that one mouse of each group was in each of 10 screen-floor cages. At 48 h postchallenge, five randomly chosen mice of each group were sacrified. Their entire small and large (colon and cecum) intestines were removed separately, with the contents of the two segments being prevented from mixing. Feces were collected at this time from the remaining mice, and these animals were observed for illness for 4 more days. Samples were extracted, and those of feces and large intestines were tested qualitatively for toxin to determine the colonization rate of the mouse groups. Unused portions of gut extracts were stored at 4°C. When toxin was found in the large intestine, the saved extracts of that animal were titrated for toxin.
Duration of colonization. The previous study of C. botulinum colonization of metronidazole-treated mice included a determination of the total LD50 of toxin in the large intestines of mice sacrificed on different days after challenge with 105 type A spores (3). A similar study was done except that test samples were feces from the same mice. Metronidazoletreated mice were challenged with 105 type B spores and were immediately given ip 20 IU of type B antitoxin, a treatment that does not affect intraintestinal toxin production but prevents overt botulism in C. botulinum-monoassociated mice (10) . Freshly excreted feces were collected on successive days from each of three C. botulinum-colonized mice, and these samples were titrated for type B toxin. RESULTS Responses to type B spores. Metronidazole-treated mice were separated into five groups of 10 mice each. Mice of one group were controls fed saline; those of other groups were challenged with 102, 103, 104, or 105 C. botulinum type B spores. Intestinal colonization rates, determined with feces collected from five mice, were related to inoculum sizes: none of the tested control mice were colonized, but 60, 80, 100, and 100% of mice receiving the successively larger doses were colonized (Fig. 1A) . Titrations of toxin-positive feces of three mice in each group indicated higher concentrations in the feces of mice given larger spore doses.
Mice were apparently healthy at the time feces were collected for the toxin test 48 h postchallenge, but some mice died during the following 18 h after developing a typical botulism syndrome (incubation of <2.75 days). These illnesses and those beginning during the next 2 days were usually fatal. Morbidity rates were related to challenge doses, but reached maxima by postchallenge day 5 regardless of challenge dose. Illnesses with incubations of more than 4 days did not usually progress beyond the mild stage. Observations were terminated after day 6 since new illness did not occur and sick mice began to recover after this time.
Although none of the five control mice tested were colonized 2 days after the start of the experiment, one of these tested mice was found dead on day 5. In other experiments, controls remained healthy, or (rarely) up to 2 of 10 developed botulism on day 4 or 5.
Although the syndrome of test mice was indistinguishable from that after i.p. injection of highly purified botulinum toxin, a different test was done to show that the illness was botulism. In the experiment (Table 1) , metronidazole-treated mice were divided into two groups of 10 (3) . Since the spore suspension of the previous study had been in the laboratory for several years and that of the present work was a newly prepared one made with the same culture strain, an experiment was done to determine whether spores lost infectivity with age. The old (Table 2) .
Excluding uncolonized mouse no. 3, toxin amounts in the large intestine 48 h after challenge with different numbers of spores were not significantly different (P > 0.05), although averages were 5,050 LD50 after low challenge dose versus 9,900 LD50 after the high dose. Average amounts in the small intestines were also not significantly different when all tested animals were considered. However, when mouse no. 7 was omitted because it differed from others of the group, the average in this part of the gut after the larger inoculum (2,280 LD50) was greater (P < 0.05) than that after the smaller inoculum (210 LD50).
Morbidity among the five observed mice of each group was within the ranges expected from earlier findings (Fig.  1A) . All mice given the larger inoculum died of botulism within 3 days, and among mice given the low dose, two, both excreting toxin on postchallenge day 2, developed botulism on day 4 and died on day 5.
Type A spores gave similar results (Table 3) . Toxin amounts in the large guts (average, 2,160 LD50 after low challenge versus 5,740 LD50 after high challenge) were not statistically different. Amounts in the small intestines (average, 160 versus 745 LD50) also were not different statistically when findings of all mice were used, but were different when mouse no. 10 was excluded. DISCUSSION
In the previous study of metronidazole-treated mice (3), illness was seen when mice were challenged with 105 type A spores. However, the infrequent and random occurrence of illness, together with the possibility of ingested toxin being the cause, led to the conclusion that the colonization is essentially nonsymptomatic. The findings of the present study permit the opposite conclusion: the animal model developed systemic botulism without ingesting toxin. The new conclusion is made possible by the experimental design. Since most of the feces fell through the screen floors beyond reach of the occupants, the opportunity for coprophagy was minimized and the morbidity rate of control mice (treated with metronidazole but not receiving a spore inoculum) was usually <10%. The few illnesses among controls were acquired from test mice since they occurred (i) even if the animal was not colonized by the pathogen 48 h after the start of the experiment, and (ii) at least 1 day after one or more spore-challenged cagemates became ill. Moreover, frequencies of coprophagically acquired botulism were made equal for all mouse groups by having one mouse of every group in each cage. In this situation, the true morbidity rate, which includes only illness caused by toxin entering the circulation directly after production, is the difference be- Intestinal segments assayed for toxin were obtained 48 h postchallenge since colonization rates and toxin amounts in the large intestines are usually maximal (3) and fecal toxin concentrations are highest at this time. Additionally, toxin causing the illnesses with the shorter incubation times would likely be absorbed into the bloodstream before or around this time. Since sampling time precedes illness, information is not available on the distribution of toxin in the gut of a mouse that developed botulism. However, if systemic botulism depends solely on the toxin levels in the large gut, it can be suggested that more mice should have developed botulism since toxin levels after 102 spores overlap those produced by the 105-spore inoculum.
Botulinum toxin injected into the lumen of the lower bowel is poorly absorbed into the bloodstream (4), but it is possible that the presence of a relatively high toxin level over an extended period of many hours may increase the chances of some toxin being absorbed. However, if this is the case, it would seem that .1,000 LD50s should be enough to cause botulism so that the 102-spore dose should have caused more illness than was found.
Few samples were tested, but both type A and B morbidity rates were better correlated with toxin levels in the small intestine than in the large gut. Although not determined in the present work, most of the toxin in the small intestine is probably in the ileum, as found in C. botulinum-monoassociated mice (10) . Toxin in this part of the gut is more likely to cause systemic effects since it is more readily absorbed into the circulation than is toxin in the large gut (5).
Toxin amount in the small intestine was usually related to what was in the large bowel, but simple retrograde transfer from the main pool in the lower gut does not completely explain the relative amounts in the small versus the large intestine. The constipation that precedes systemic illness in clinical infant botulism (1) is not seen in mice, but it is possible that high levels of early formed toxin in the large bowel might act locally in a manner allowing more toxin into the ileum, or allowing the pathogen to multiply more in the ileum and concomitantly produce a larger amount of toxin. Whatever the correct reason, the finding of relatively large amounts of toxin in the large bowel of mice that remained healthy suggests that nonsymptomatic infections of human infants may be a more common occurrence than has been reported.
